Abstract
Liver cancer has a poor prognosis predominantly resulting from tumour heterogeneity and limited treatment options. The two predominant types of liver cancer are Hepatocellular carcinoma (HCC) and Intrahepatic Cholangiocarcinoma (iCCA). CD44v6, a splice variant of the hyaluronic acid receptor CD44, is a marker for cancer stem cells, and is known to impact tumour formation and metastasis in several cancers. The expression of CD44v6 dramatically increases in liver epithelial cells upon carcinogen exposure.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
